Dejan Micic to Anti-Inflammatory Agents
This is a "connection" page, showing publications Dejan Micic has written about Anti-Inflammatory Agents.
Connection Strength
0.029
-
Systematic review with meta-analysis: the efficacy and safety of CT-P13, a biosimilar of anti-tumour necrosis factor-a agent (infliximab), in inflammatory bowel diseases. Aliment Pharmacol Ther. 2017 04; 45(8):1043-1057.
Score: 0.029